These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35989210)

  • 21. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
    Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
    Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
    Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
    PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Malawi.
    Rubenstein BL; Chinkhumba J; Chilima E; Kwizombe C; Malpass A; Cash S; Wright K; Troell P; Nsona H; Kachale F; Ali D; Kaunda E; Lankhulani S; Kayange M; Mathanga DP; Munthali J; Gutman JR
    Malar J; 2022 Jun; 21(1):195. PubMed ID: 35729612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new strategy and its effect on adherence to intermittent preventive treatment of malaria in pregnancy in Uganda.
    Mbonye AK; Yanow S; Birungi J; Magnussen P
    BMC Pregnancy Childbirth; 2013 Sep; 13():178. PubMed ID: 24053142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.
    Hill J; Dellicour S; Bruce J; Ouma P; Smedley J; Otieno P; Ombock M; Kariuki S; Desai M; Hamel MJ; ter Kuile FO; Webster J
    PLoS One; 2013; 8(6):e64913. PubMed ID: 23798997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey.
    Sangho O; Tounkara M; Whiting-Collins LJ; Beebe M; Winch PJ; Doumbia S
    Malar J; 2021 May; 20(1):231. PubMed ID: 34022901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial.
    Lingani M; Zango SH; Valéa I; Samadoulougou S; Somé G; Sanou M; Kaboré B; Rouamba T; Sorgho H; Tahita MC; Derra K; Dramaix M; Tinto H; Donnen P; Robert A
    Malar J; 2023 Mar; 22(1):101. PubMed ID: 36932435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-based delivery of intermittent preventive treatment of malaria in pregnancy in Burkina Faso: a qualitative study.
    Burke D; Tiendrebeogo J; Emerson C; Youll S; Gutman J; Badolo O; Savadogo Y; Vibbert K; Wolf K; Brieger W
    Malar J; 2021 Jun; 20(1):277. PubMed ID: 34162384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda.
    Sangaré LR; Stergachis A; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Weiss NS
    PLoS One; 2010 Nov; 5(11):e15066. PubMed ID: 21124732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania.
    Exavery A; Mbaruku G; Mbuyita S; Makemba A; Kinyonge IP; Kweka H
    Malar J; 2014 Jan; 13():22. PubMed ID: 24423279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
    Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
    Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
    Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
    Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
    PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey.
    Hill J; Kayentao K; Touré M; Diarwara S; Bruce J; Smedley J; Doumbo OK; ter Kuile FO; Webster J
    PLoS One; 2014; 9(3):e92102. PubMed ID: 24651078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.
    Adewole AO; Fawole O; Ajayi I; Yusuf B; Oladimeji A; Waziri E; Nguku P; Ajumobi O
    Pan Afr Med J; 2019; 33():101. PubMed ID: 31489079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.